| <!DOCTYPE html> |
| <html lang="en"> |
| <head> |
| <meta charset="UTF-8"> |
| <meta name="viewport" content="width=device-width, initial-scale=1.0"> |
| <title>Caustin IP & Public Trust Platform — Portfolio</title> |
| <style> |
| :root { |
| --navy: #1A237E; |
| --navy-light: #283593; |
| --navy-dark: #0D1245; |
| --accent: #8B0000; |
| --gold: #C5A572; |
| --bg: #F5F6FA; |
| --card: #FFFFFF; |
| --text: #1A1A2E; |
| --text-muted: #555555; |
| --border: #E0E0E0; |
| --shadow: 0 4px 20px rgba(26,35,126,0.08); |
| --shadow-hover: 0 8px 30px rgba(26,35,126,0.15); |
| --radius: 12px; |
| --transition: all 0.3s cubic-bezier(0.4,0,0.2,1); |
| } |
| * { margin:0; padding:0; box-sizing:border-box; } |
| body { |
| font-family: 'Segoe UI', system-ui, -apple-system, sans-serif; |
| background: var(--bg); |
| color: var(--text); |
| line-height:1.6; |
| overflow-x:hidden; |
| } |
| a { text-decoration:none; color: inherit; } |
| |
| |
| .hero { |
| background: linear-gradient(135deg, var(--navy-dark) 0%, var(--navy) 60%, var(--navy-light) 100%); |
| color: white; |
| padding: 80px 20px 60px; |
| text-align:center; |
| position:relative; |
| overflow:hidden; |
| } |
| .hero::before { |
| content:''; |
| position:absolute; |
| top:-50%; left:-50%; |
| width:200%; height:200%; |
| background: radial-gradient(circle at 30% 70%, rgba(197,165,114,0.08) 0%, transparent 50%), |
| radial-gradient(circle at 70% 30%, rgba(255,255,255,0.03) 0%, transparent 50%); |
| animation: drift 20s ease-in-out infinite; |
| } |
| @keyframes drift { |
| 0%,100% { transform: translate(0,0) rotate(0deg); } |
| 50% { transform: translate(-20px,10px) rotate(1deg); } |
| } |
| .hero-content { position:relative; z-index:2; max-width:900px; margin:0 auto; } |
| .hero h1 { |
| font-size: clamp(2rem, 5vw, 3.2rem); |
| font-weight:800; |
| letter-spacing:-0.02em; |
| margin-bottom:12px; |
| text-shadow: 0 2px 10px rgba(0,0,0,0.2); |
| } |
| .hero .tagline { |
| font-size: clamp(1rem, 2.5vw, 1.3rem); |
| opacity:0.85; |
| font-weight:300; |
| margin-bottom:24px; |
| } |
| .hero .meta { |
| display:flex; flex-wrap:wrap; justify-content:center; gap:16px; |
| font-size:0.85rem; opacity:0.7; |
| } |
| .hero .meta span { |
| background: rgba(255,255,255,0.1); |
| padding: 6px 14px; |
| border-radius: 20px; |
| backdrop-filter: blur(4px); |
| } |
| |
| |
| .nav { |
| position:sticky; top:0; z-index:100; |
| background: rgba(255,255,255,0.95); |
| backdrop-filter: blur(12px); |
| border-bottom: 1px solid var(--border); |
| padding: 0 20px; |
| } |
| .nav-inner { |
| max-width: 1200px; margin: 0 auto; |
| display:flex; align-items:center; justify-content:space-between; |
| height: 60px; |
| } |
| .nav-logo { |
| font-weight:800; color: var(--navy); font-size:1.1rem; |
| display:flex; align-items:center; gap:8px; |
| } |
| .nav-logo::before { |
| content:''; width:8px; height:8px; background: var(--gold); |
| border-radius:50%; display:inline-block; |
| } |
| .nav-links { |
| display:flex; gap:28px; list-style:none; |
| } |
| .nav-links a { |
| font-size:0.9rem; font-weight:500; color: var(--text-muted); |
| transition: var(--transition); position:relative; |
| } |
| .nav-links a:hover, .nav-links a.active { |
| color: var(--navy); |
| } |
| .nav-links a.active::after { |
| content:''; position:absolute; bottom:-18px; left:0; right:0; |
| height:3px; background: var(--navy); border-radius:2px; |
| } |
| |
| |
| .section { |
| max-width: 1200px; margin: 0 auto; padding: 60px 20px; |
| } |
| .section-title { |
| font-size: 1.8rem; font-weight:700; color: var(--navy); |
| margin-bottom: 8px; display:flex; align-items:center; gap:12px; |
| } |
| .section-title .icon { |
| width:36px; height:36px; background: var(--navy); |
| border-radius: 8px; display:flex; align-items:center; justify-content:center; |
| color: white; font-size:1.1rem; |
| } |
| .section-subtitle { |
| color: var(--text-muted); font-size:1rem; margin-bottom:32px; |
| padding-left: 48px; |
| } |
| |
| |
| .card-grid { |
| display: grid; |
| grid-template-columns: repeat(auto-fill, minmax(340px, 1fr)); |
| gap: 24px; |
| } |
| .card { |
| background: var(--card); |
| border-radius: var(--radius); |
| box-shadow: var(--shadow); |
| padding: 28px; |
| transition: var(--transition); |
| border: 1px solid var(--border); |
| position:relative; overflow:hidden; |
| } |
| .card:hover { |
| transform: translateY(-4px); |
| box-shadow: var(--shadow-hover); |
| border-color: var(--navy-light); |
| } |
| .card::before { |
| content:''; position:absolute; top:0; left:0; right:0; height:4px; |
| background: linear-gradient(90deg, var(--navy), var(--gold)); |
| opacity:0; transition: var(--transition); |
| } |
| .card:hover::before { opacity:1; } |
| .card-header { |
| display:flex; align-items:flex-start; justify-content:space-between; margin-bottom:16px; |
| } |
| .card-badge { |
| font-size:0.7rem; font-weight:700; text-transform:uppercase; |
| letter-spacing:0.05em; padding: 4px 10px; border-radius: 4px; |
| } |
| .badge-cp { background: #E8EAF6; color: var(--navy); } |
| .badge-sg { background: #E0F2F1; color: #00695C; } |
| .badge-da { background: #FFF3E0; color: #E65100; } |
| .badge-sr { background: #F3E5F5; color: #6A1B9A; } |
| .badge-lf { background: #E8F5E9; color: #2E7D32; } |
| .badge-tech { background: #E3F2FD; color: #1565C0; } |
| .badge-sec { background: #FFEBEE; color: var(--accent); } |
| .card-title { |
| font-size:1.15rem; font-weight:700; color: var(--navy); margin-bottom:8px; |
| } |
| .card-desc { |
| font-size:0.92rem; color: var(--text-muted); line-height:1.6; |
| } |
| .card-meta { |
| margin-top:16px; padding-top:16px; border-top:1px solid var(--border); |
| display:flex; flex-wrap:wrap; gap:12px; font-size:0.8rem; |
| } |
| .card-meta span { |
| display:flex; align-items:center; gap:4px; |
| color: var(--text-muted); |
| } |
| .card-meta .auth-id { |
| color: var(--accent); font-weight:700; font-family: 'SF Mono', monospace; |
| font-size:0.78rem; |
| } |
| |
| |
| .matrix-table { |
| width:100%; border-collapse: collapse; margin-top:20px; |
| background: var(--card); border-radius: var(--radius); |
| overflow:hidden; box-shadow: var(--shadow); |
| } |
| .matrix-table th { |
| background: var(--navy); color: white; |
| padding: 14px 16px; text-align:left; |
| font-size:0.85rem; font-weight:600; text-transform:uppercase; |
| letter-spacing:0.03em; |
| } |
| .matrix-table td { |
| padding: 14px 16px; border-bottom: 1px solid var(--border); |
| font-size:0.9rem; vertical-align:top; |
| } |
| .matrix-table tr:hover td { background: #F8F9FF; } |
| .matrix-table .auth-cell { |
| font-family: 'SF Mono', monospace; font-weight:700; |
| color: var(--accent); font-size:0.85rem; white-space:nowrap; |
| } |
| .matrix-table .domain-header { |
| background: var(--navy-light); color: white; |
| font-weight:700; font-size:0.95rem; |
| } |
| |
| |
| .exhibit-panel { |
| background: linear-gradient(135deg, var(--navy-dark), var(--navy)); |
| color: white; border-radius: var(--radius); |
| padding: 40px; margin-top: 24px; |
| position:relative; overflow:hidden; |
| } |
| .exhibit-panel::before { |
| content:''; position:absolute; top:0; right:0; |
| width:300px; height:300px; |
| background: radial-gradient(circle, rgba(197,165,114,0.15) 0%, transparent 70%); |
| } |
| .exhibit-panel h3 { |
| font-size:1.4rem; margin-bottom:16px; position:relative; z-index:2; |
| } |
| .exhibit-grid { |
| display:grid; grid-template-columns: repeat(auto-fill, minmax(260px, 1fr)); |
| gap:20px; position:relative; z-index:2; |
| } |
| .exhibit-item { |
| background: rgba(255,255,255,0.08); |
| border-radius: 8px; padding: 20px; |
| border: 1px solid rgba(255,255,255,0.1); |
| transition: var(--transition); |
| } |
| .exhibit-item:hover { |
| background: rgba(255,255,255,0.14); |
| transform: translateY(-2px); |
| } |
| .exhibit-item h4 { |
| font-size:0.95rem; margin-bottom:8px; color: var(--gold); |
| } |
| .exhibit-item p { |
| font-size:0.82rem; opacity:0.8; line-height:1.5; |
| } |
| .exhibit-item .file-link { |
| display:inline-block; margin-top:10px; |
| font-size:0.78rem; color: var(--gold); |
| border-bottom: 1px solid var(--gold); |
| padding-bottom: 1px; |
| } |
| |
| |
| .timeline { |
| position:relative; padding-left: 32px; |
| } |
| .timeline::before { |
| content:''; position:absolute; left:8px; top:0; bottom:0; |
| width:2px; background: linear-gradient(180deg, var(--navy), var(--gold)); |
| } |
| .timeline-item { |
| position:relative; margin-bottom: 32px; |
| padding-left: 24px; |
| } |
| .timeline-item::before { |
| content:''; position:absolute; left:-28px; top:4px; |
| width:14px; height:14px; background: var(--card); |
| border: 3px solid var(--navy); border-radius:50%; |
| } |
| .timeline-item.active::before { |
| background: var(--gold); border-color: var(--gold); |
| box-shadow: 0 0 0 4px rgba(197,165,114,0.2); |
| } |
| .timeline-date { |
| font-size:0.78rem; color: var(--text-muted); |
| font-weight:600; text-transform:uppercase; letter-spacing:0.05em; |
| margin-bottom:4px; |
| } |
| .timeline-title { |
| font-size:1.05rem; font-weight:700; color: var(--navy); |
| margin-bottom:6px; |
| } |
| .timeline-desc { |
| font-size:0.9rem; color: var(--text-muted); |
| } |
| |
| |
| .footer { |
| background: var(--navy-dark); color: white; |
| padding: 40px 20px; text-align:center; |
| margin-top: 40px; |
| } |
| .footer p { |
| opacity:0.6; font-size:0.85rem; |
| } |
| .footer .footer-links { |
| display:flex; justify-content:center; gap:24px; |
| margin-bottom:16px; flex-wrap:wrap; |
| } |
| .footer .footer-links a { |
| opacity:0.7; font-size:0.85rem; transition: var(--transition); |
| } |
| .footer .footer-links a:hover { opacity:1; color: var(--gold); } |
| |
| |
| @media (max-width: 768px) { |
| .nav-links { display:none; } |
| .card-grid { grid-template-columns: 1fr; } |
| .exhibit-grid { grid-template-columns: 1fr; } |
| .section { padding: 40px 16px; } |
| } |
| |
| |
| .fade-in { |
| opacity:0; transform: translateY(20px); |
| transition: opacity 0.6s ease, transform 0.6s ease; |
| } |
| .fade-in.visible { |
| opacity:1; transform: translateY(0); |
| } |
| </style> |
| </head> |
| <body> |
|
|
| |
| <section class="hero"> |
| <div class="hero-content"> |
| <h1>Caustin IP & Public Trust Platform</h1> |
| <p class="tagline">Jurisprudential Technology at the Intersection of Constitutional Law, Bioinformatics, AI Architecture & Municipal Policy</p> |
| <div class="meta"> |
| <span>Baltimore, MD 21223</span> |
| <span>BSBS Certified</span> |
| <span>GPRS-Secure++</span> |
| <span>HSPA-9 Architecture</span> |
| </div> |
| </div> |
| </section> |
|
|
| |
| <nav class="nav"> |
| <div class="nav-inner"> |
| <div class="nav-logo">Caustin IP</div> |
| <ul class="nav-links"> |
| <li><a href="#matrix" class="active">Authority Matrix</a></li> |
| <li><a href="#projects">Projects</a></li> |
| <li><a href="#exhibits">Exhibits</a></li> |
| <li><a href="#securities">Securities</a></li> |
| <li><a href="#timeline">Timeline</a></li> |
| </ul> |
| </div> |
| </nav> |
|
|
| |
| <section class="section" id="matrix"> |
| <h2 class="section-title"><span class="icon">⚖</span> Master Authority Matrix</h2> |
| <p class="section-subtitle">Controlling reference system for all propositions, exhibits, authorities, and legislative proposals</p> |
|
|
| <table class="matrix-table"> |
| <tr><th>Authority ID</th><th>Proposition</th><th>Supporting Evidence</th><th>Volumes</th></tr> |
| <tr><td colspan="4" class="domain-header">CONSTITUTIONAL PRIVACY AUTHORITIES (CP)</td></tr> |
| <tr><td class="auth-cell">CP-001</td><td>Genomic information is immutable.</td><td>EX-1001 through EX-1099</td><td>Vol. I, IV</td></tr> |
| <tr><td class="auth-cell">CP-002</td><td>Genomic information functions as a persistent identifier.</td><td>EX-1100 through EX-1199</td><td>Vol. I, IV</td></tr> |
| <tr><td class="auth-cell">CP-003</td><td>Genomic information possesses predictive capabilities extending beyond present medical conditions.</td><td>EX-1200 through EX-1299</td><td>Vol. I, IV</td></tr> |
| <tr><td class="auth-cell">CP-004</td><td>Disclosure of genomic information may reveal information regarding biological relatives.</td><td>EX-1300 through EX-1399</td><td>Vol. I, IV</td></tr> |
| <tr><td class="auth-cell">CP-005</td><td>Large-scale genomic aggregation creates privacy risks distinct from traditional medical record systems.</td><td>EX-1400 through EX-1499</td><td>Vol. I, II</td></tr> |
|
|
| <tr><td colspan="4" class="domain-header">SECURITY AND GOVERNANCE AUTHORITIES (SG)</td></tr> |
| <tr><td class="auth-cell">SG-001</td><td>Data minimization reduces exposure risk.</td><td>BSBS Artifact AU-10; GPRS-Secure++ Pipeline Docs</td><td>Vol. II, III</td></tr> |
| <tr><td class="auth-cell">SG-002</td><td>Federated computation reduces centralized data accumulation.</td><td>GPRS-Secure++ Federated Spec; HSPA-9 Benchmark</td><td>Vol. II, III</td></tr> |
| <tr><td class="auth-cell">SG-003</td><td>Trusted execution environments provide hardware-assisted isolation.</td><td>Fort McHenry HSM Model; HSPA-9 SPU Specs</td><td>Vol. II, III</td></tr> |
| <tr><td class="auth-cell">SG-004</td><td>Differential privacy can reduce disclosure risks.</td><td>Caustin Advanced Analytics Report § 2.1–2.3</td><td>Vol. II, IV</td></tr> |
| <tr><td class="auth-cell">SG-005</td><td>Cryptographic auditability improves accountability.</td><td>BSBS Merkle Tree Spec; SHA3-256 Ledger Protocol</td><td>Vol. II, III</td></tr> |
| <tr><td class="auth-cell">SG-006</td><td>Post-quantum cryptography may mitigate future decryption threats.</td><td>FIPS 203/204 Mapping; ML-KEM/ML-DSA Test Vectors</td><td>Vol. II, III</td></tr> |
|
|
| <tr><td colspan="4" class="domain-header">DISABILITY AND ACCESSIBILITY AUTHORITIES (DA)</td></tr> |
| <tr><td class="auth-cell">DA-001</td><td>Genomic evidence should not serve as a sole determinant of disability status.</td><td>ADA Compliance Framework; Caustin IP Policy Brief</td><td>Vol. I, IV</td></tr> |
| <tr><td class="auth-cell">DA-002</td><td>Accessibility technologies may improve administrative participation.</td><td>BSBS AC-2/AC-3 Control Mapping</td><td>Vol. I, IV</td></tr> |
| <tr><td class="auth-cell">DA-003</td><td>Objective evidence frameworks can supplement existing adjudicatory systems.</td><td>SSA SSR 16-4p Crosswalk</td><td>Vol. I, IV</td></tr> |
| <tr><td class="auth-cell">DA-004</td><td>Administrative modernization may improve claimant outcomes.</td><td>Municipal Policy Advisory Reports</td><td>Vol. I, IV</td></tr> |
|
|
| <tr><td colspan="4" class="domain-header">SCIENTIFIC RECORD AUTHORITIES (SR)</td></tr> |
| <tr><td class="auth-cell">SR-001</td><td>Polygenic risk scores remain an evolving research methodology.</td><td>GPRS-Secure++ Validation Studies</td><td>Vol. III, IV</td></tr> |
| <tr><td class="auth-cell">SR-002</td><td>Clinical validity and utility require independent evaluation.</td><td>HSPA-9 Benchmark Suite; Independent Lab Reports</td><td>Vol. III, IV</td></tr> |
| <tr><td class="auth-cell">SR-003</td><td>Scientific reproducibility is necessary for evidentiary reliability.</td><td>Reproducibility Protocol v2.1; Daubert Standard Mapping</td><td>Vol. III, IV</td></tr> |
| <tr><td class="auth-cell">SR-004</td><td>Research findings should be distinguished from legal conclusions.</td><td>Caustin IP Jurisprudential Methodology</td><td>Vol. III, IV</td></tr> |
|
|
| <tr><td colspan="4" class="domain-header">LEGISLATIVE FRAMEWORK AUTHORITIES (LF)</td></tr> |
| <tr><td class="auth-cell">LF-001</td><td>Genomic information warrants enhanced statutory protection.</td><td>BSBS Legislative Policy Brief; HIPAA/GINA/GDPR Crosswalk</td><td>Vol. I, II</td></tr> |
| <tr><td class="auth-cell">LF-002</td><td>Patient-controlled consent mechanisms should be strengthened.</td><td>GPRS-Secure++ Consent Layer Spec</td><td>Vol. I, II</td></tr> |
| <tr><td class="auth-cell">LF-003</td><td>Independent auditing improves trust and accountability.</td><td>BSBS Certificate Transparency Log; Fort McHenry HSM Attestation</td><td>Vol. I, II</td></tr> |
| <tr><td class="auth-cell">LF-004</td><td>Government genomic systems require heightened safeguards.</td><td>Municipal Policy Advisory; Federal Cross-Domain Framework</td><td>Vol. I, II</td></tr> |
| <tr><td class="auth-cell">LF-005</td><td>Secondary-use restrictions may reduce privacy harms.</td><td>GPRS-Secure++ Tokenization Protocol; Non-Reversible Linkage Spec</td><td>Vol. I, II</td></tr> |
| </table> |
| </section> |
|
|
| |
| <section class="section" id="projects"> |
| <h2 class="section-title"><span class="icon">⚙</span> Core Technical Projects</h2> |
| <p class="section-subtitle">Architectural pillars of the Caustin IP & Public Trust Platform</p> |
|
|
| <div class="card-grid"> |
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-tech">Architecture</span> |
| </div> |
| <h3 class="card-title">HSPA-9 Secure Processing Unit</h3> |
| <p class="card-desc">A custom secure processing architecture (distinct from HSPA-8) with side-channel resistant execution, dedicated entropy sources, and hardware-enforced memory isolation for cryptographic operations. Provides the computational backbone for all BSBS and GPRS-Secure++ operations.</p> |
| <div class="card-meta"> |
| <span class="auth-id">[SG-003]</span> |
| <span class="auth-id">[SG-006]</span> |
| <span class="auth-id">[SR-002]</span> |
| <span>Vol. III</span> |
| </div> |
| </div> |
|
|
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-tech">Pipeline</span> |
| </div> |
| <h3 class="card-title">GPRS-Secure++ Genomic Pipeline</h3> |
| <p class="card-desc">Cross-domain data handling pipeline ensuring genomic and financial metadata remain segregated, linked only via non-reversible SHA3-256 tokens. Supports federated computation, differential privacy, and patient-controlled consent mechanisms across HIPAA, GINA, ADA, and GDPR frameworks.</p> |
| <div class="card-meta"> |
| <span class="auth-id">[SG-001]</span> |
| <span class="auth-id">[SG-002]</span> |
| <span class="auth-id">[SG-004]</span> |
| <span class="auth-id">[LF-002]</span> |
| <span>Vol. II, IV</span> |
| </div> |
| </div> |
|
|
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-sec">Security</span> |
| </div> |
| <h3 class="card-title">Baltimore Secure Backbone System (BSBS)</h3> |
| <p class="card-desc">Municipal-grade zero-trust security infrastructure with Fort McHenry HSM attestation, SHA3-256 Merkle-chained audit logs, certificate transparency, and fail-closed incident response protocols. Mapped to NIST SP 800-207 and NIST SP 800-53 Rev. 5 control families.</p> |
| <div class="card-meta"> |
| <span class="auth-id">[SG-003]</span> |
| <span class="auth-id">[SG-005]</span> |
| <span class="auth-id">[LF-003]</span> |
| <span>Vol. II, III</span> |
| </div> |
| </div> |
|
|
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-tech">Patent</span> |
| </div> |
| <h3 class="card-title">USB Electrochemical Genotyping</h3> |
| <p class="card-desc">Filed patent for hardware-rooted identity attestation using electrochemical biosensor integration. Enables biometric-to-cryptographic binding for high-assurance transactions, linking genomic identity to cryptographic credentials without exposing raw genetic data.</p> |
| <div class="card-meta"> |
| <span class="auth-id">[CP-001]</span> |
| <span class="auth-id">[CP-002]</span> |
| <span class="auth-id">[SG-003]</span> |
| <span>Vol. III, IV</span> |
| </div> |
| </div> |
|
|
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-cp">Constitutional</span> |
| </div> |
| <h3 class="card-title">Constitutional Privacy Framework</h3> |
| <p class="card-desc">Jurisprudential methodology establishing that genomic immutability, persistent identification, predictive capability, familial disclosure risk, and large-scale aggregation harms trigger enhanced Fourth Amendment and Due Process protections under the Fifth and Fourteenth Amendments.</p> |
| <div class="card-meta"> |
| <span class="auth-id">[CP-001]</span> |
| <span class="auth-id">[CP-002]</span> |
| <span class="auth-id">[CP-003]</span> |
| <span class="auth-id">[CP-004]</span> |
| <span class="auth-id">[CP-005]</span> |
| <span>Vol. I, IV</span> |
| </div> |
| </div> |
|
|
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-da">Accessibility</span> |
| </div> |
| <h3 class="card-title">ADA-Compliant Administrative Modernization</h3> |
| <p class="card-desc">Objective evidence frameworks supplementing existing SSA adjudicatory systems. Accessibility technologies (FIDO2 hardware tokens with tactile interfaces, screen-reader compatible portals) improve claimant participation and outcomes under ADA and SSA SSR 16-4p.</p> |
| <div class="card-meta"> |
| <span class="auth-id">[DA-001]</span> |
| <span class="auth-id">[DA-002]</span> |
| <span class="auth-id">[DA-003]</span> |
| <span class="auth-id">[DA-004]</span> |
| <span>Vol. I, IV</span> |
| </div> |
| </div> |
| </div> |
| </section> |
|
|
| |
| <section class="section" id="exhibits"> |
| <h2 class="section-title"><span class="icon">📄</span> Portfolio Exhibits</h2> |
| <p class="section-subtitle">Documented evidence, securities, and regulatory artifacts</p> |
|
|
| <div class="exhibit-panel"> |
| <h3>💼 Securities & Financial Instruments</h3> |
| <div class="exhibit-grid"> |
| <div class="exhibit-item"> |
| <h4>USEC Inc. Prospectus</h4> |
| <p>$500,000,000 Senior Notes Offering — 6⅝% Due 2006 / 6¾% Due 2009. Prospectus dated January 14, 1999. Underwriters: J.P. Morgan, Merrill Lynch, Lehman Brothers, NationsBanc Montgomery Securities, Blaylock & Partners.</p> |
| <span class="file-link">EX-SE-001 | Dated: Jan 14, 1999</span> |
| </div> |
| <div class="exhibit-item"> |
| <h4>Cover Letter — Securities Order</h4> |
| <p>Formal cover letter to Chief Investment Officer establishing institutional framework, Authority Matrix citations (CP-001, CP-002, CP-005, SG-001, SG-005, SG-006, LF-001, LF-003), and BSBS custody protocols for USEC senior notes acquisition.</p> |
| <span class="file-link">EX-SE-002 | Dated: [Insert Date]</span> |
| </div> |
| <div class="exhibit-item"> |
| <h4>Official Order Request</h4> |
| <p>Execution-ready order form with securities specification, settlement instructions, representations & warranties, multi-signature authorization, and broker-dealer acknowledgment for USEC senior notes.</p> |
| <span class="file-link">EX-SE-003 | Dated: 6/22/2026</span> |
| </div> |
| <div class="exhibit-item"> |
| <h4>Secure Bank Account Request</h4> |
| <p>Request to establish institutional account with post-quantum cryptography (ML-KEM-768, ML-DSA-65), zero-trust architecture, and verifiable audit trails. Includes USEC Prospectus as structural baseline exhibit.</p> |
| <span class="file-link">EX-FI-001 | Formal Letter + Technical Spec</span> |
| </div> |
| </div> |
| </div> |
|
|
| <div class="card-grid" style="margin-top:24px;"> |
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-lf">Legislative</span> |
| </div> |
| <h3 class="card-title">BSBS Legislative Policy Brief</h3> |
| <p class="card-desc">Statutory recommendations for genomic information protection, patient-controlled consent, independent auditing mandates, government system safeguards, and secondary-use restrictions. Mapped to LF-001 through LF-005.</p> |
| <div class="card-meta"> |
| <span class="auth-id">[LF-001]</span> |
| <span class="auth-id">[LF-002]</span> |
| <span class="auth-id">[LF-003]</span> |
| <span class="auth-id">[LF-004]</span> |
| <span class="auth-id">[LF-005]</span> |
| </div> |
| </div> |
|
|
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-sr">Scientific</span> |
| </div> |
| <h3 class="card-title">GPRS-Secure++ Validation Studies</h3> |
| <p class="card-desc">Independent evaluation of polygenic risk score methodologies, clinical validity assessments, reproducibility protocols under Daubert standards, and clear demarcation between research findings and legal conclusions.</p> |
| <div class="card-meta"> |
| <span class="auth-id">[SR-001]</span> |
| <span class="auth-id">[SR-002]</span> |
| <span class="auth-id">[SR-003]</span> |
| <span class="auth-id">[SR-004]</span> |
| </div> |
| </div> |
|
|
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-sg">Technical</span> |
| </div> |
| <h3 class="card-title">HSPA-9 Benchmark Suite</h3> |
| <p class="card-desc">Performance and security benchmarks for the HSPA-9 Secure Processing Unit, including side-channel resistance testing, entropy source validation, ML-KEM/ML-DSA throughput metrics, and memory isolation verification.</p> |
| <div class="card-meta"> |
| <span class="auth-id">[SG-003]</span> |
| <span class="auth-id">[SG-006]</span> |
| <span class="auth-id">[SR-002]</span> |
| </div> |
| </div> |
|
|
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-cp">Privacy</span> |
| </div> |
| <h3 class="card-title">Genomic Privacy Impact Assessment</h3> |
| <p class="card-desc">Comprehensive analysis of genomic immutability, persistent identification risks, predictive capability disclosures, familial inference harms, and large-scale aggregation threats under HIPAA, GINA, ADA, and GDPR.</p> |
| <div class="card-meta"> |
| <span class="auth-id">[CP-001]</span> |
| <span class="auth-id">[CP-002]</span> |
| <span class="auth-id">[CP-003]</span> |
| <span class="auth-id">[CP-004]</span> |
| <span class="auth-id">[CP-005]</span> |
| </div> |
| </div> |
| </div> |
| </section> |
|
|
| |
| <section class="section" id="securities"> |
| <h2 class="section-title"><span class="icon">💰</span> USEC Senior Notes — Order Detail</h2> |
| <p class="section-subtitle">Official Order Request executed under Master Authority Matrix governance</p> |
|
|
| <div class="card-grid"> |
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-sec">Tranche A</span> |
| </div> |
| <h3 class="card-title">6⅝% Senior Notes Due 2006</h3> |
| <p class="card-desc"> |
| <strong>Maturity:</strong> January 20, 2006<br> |
| <strong>Interest:</strong> 6⅝% per annum, paid semi-annually (Jan 20 / Jul 20)<br> |
| <strong>Offering Size:</strong> $350,000,000<br> |
| <strong>Public Offering Price:</strong> 99.746% of principal<br> |
| <strong>Underwriting Discount:</strong> 0.625%<br> |
| <strong>Proceeds to Issuer:</strong> $346,923,500<br> |
| <strong>Form:</strong> Book-entry only (DTC)<br> |
| <strong>Ranking:</strong> Unsecured senior; equal with all other unsecured senior indebtedness<br> |
| <strong>Redemption:</strong> Optional at issuer's option at principal + accrued interest + make-whole premium |
| </p> |
| <div class="card-meta"> |
| <span class="auth-id">[SG-005]</span> |
| <span class="auth-id">[LF-003]</span> |
| <span>EX-SE-001</span> |
| </div> |
| </div> |
|
|
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-sec">Tranche B</span> |
| </div> |
| <h3 class="card-title">6¾% Senior Notes Due 2009</h3> |
| <p class="card-desc"> |
| <strong>Maturity:</strong> January 20, 2009<br> |
| <strong>Interest:</strong> 6¾% per annum, paid semi-annually (Jan 20 / Jul 20)<br> |
| <strong>Offering Size:</strong> $150,000,000<br> |
| <strong>Public Offering Price:</strong> 99.527% of principal<br> |
| <strong>Underwriting Discount:</strong> 0.65%<br> |
| <strong>Proceeds to Issuer:</strong> $148,513,500<br> |
| <strong>Form:</strong> Book-entry only (DTC)<br> |
| <strong>Ranking:</strong> Unsecured senior; equal with all other unsecured senior indebtedness<br> |
| <strong>Redemption:</strong> Optional at issuer's option at principal + accrued interest + make-whole premium |
| </p> |
| <div class="card-meta"> |
| <span class="auth-id">[SG-005]</span> |
| <span class="auth-id">[LF-003]</span> |
| <span>EX-SE-001</span> |
| </div> |
| </div> |
|
|
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-sg">Security</span> |
| </div> |
| <h3 class="card-title">Custody & Security Protocols</h3> |
| <p class="card-desc"> |
| <strong>Book-Entry Verification:</strong> DTC confirmation hashed (SHA3-256) and recorded in BSBS Merkle tree within 24h [SG-005]<br><br> |
| <strong>Segregated Custody:</strong> Separate account with FIDO2 + biometric access [SG-003]<br><br> |
| <strong>Multi-Sig Controls:</strong> ML-DSA-65 (Dilithium-III) authorization from 2+ officers for transactions >$10,000 [SG-006]<br><br> |
| <strong>Quarterly Attestation:</strong> Reconciliation published to BSBS transparency log; discrepancies trigger Fort McHenry HSM fail-closed [SG-003, SG-005]<br><br> |
| <strong>Post-Quantum Readiness:</strong> All custody records maintained with SHA3-256 and ML-DSA-65 signatures [SG-006] |
| </p> |
| <div class="card-meta"> |
| <span class="auth-id">[SG-003]</span> |
| <span class="auth-id">[SG-005]</span> |
| <span class="auth-id">[SG-006]</span> |
| </div> |
| </div> |
|
|
| <div class="card fade-in"> |
| <div class="card-header"> |
| <span class="card-badge badge-lf">Compliance</span> |
| </div> |
| <h3 class="card-title">Regulatory & Constitutional Alignment</h3> |
| <p class="card-desc"> |
| <strong>Securities Act of 1933:</strong> Order placed in reliance upon registered Prospectus [LF-003]<br><br> |
| <strong>SEC Rule 15c3-3:</strong> Special reserve account for exclusive benefit of customers<br><br> |
| <strong>BSA/AML:</strong> Funds derived from lawful litigation support, bioinformatics research, public-interest technology consulting [SG-001]<br><br> |
| <strong>HIPAA/GINA/ADA/GDPR:</strong> No genomic/biometric/PII transmitted with order; all data processed under privacy frameworks [CP-001–005]<br><br> |
| <strong>Constitutional Reserve:</strong> Fifth and Fourteenth Amendment Due Process/Takings protections invoked per CP-001–005 and LF-001 |
| </p> |
| <div class="card-meta"> |
| <span class="auth-id">[CP-001]</span> |
| <span class="auth-id">[LF-001]</span> |
| <span class="auth-id">[LF-003]</span> |
| <span class="auth-id">[SG-001]</span> |
| </div> |
| </div> |
| </div> |
| </section> |
|
|
| |
| <section class="section" id="timeline"> |
| <h2 class="section-title"><span class="icon">🕐</span> Portfolio Timeline</h2> |
| <p class="section-subtitle">Key milestones in the development of the Caustin IP & Public Trust Platform</p> |
|
|
| <div class="timeline"> |
| <div class="timeline-item"> |
| <div class="timeline-date">January 14, 1999</div> |
| <div class="timeline-title">USEC Inc. Senior Notes Offering</div> |
| <div class="timeline-desc">$500,000,000 Prospectus issued — 6⅝% Due 2006 / 6¾% Due 2009. Classical institutional finance paradigm: DTC book-entry, underwriter syndication, indenture-based trust. Now serves as structural baseline for post-quantum financial architecture. <span class="auth-id">[EX-SE-001]</span></div> |
| </div> |
| <div class="timeline-item"> |
| <div class="timeline-date">Ongoing</div> |
| <div class="timeline-title">USB Electrochemical Genotyping Patent Filed</div> |
| <div class="timeline-desc">Hardware-rooted identity attestation using electrochemical biosensor integration. Enables biometric-to-cryptographic binding for high-assurance transactions. <span class="auth-id">[SG-003]</span> <span class="auth-id">[CP-001]</span></div> |
| </div> |
| <div class="timeline-item"> |
| <div class="timeline-date">Ongoing</div> |
| <div class="timeline-title">HSPA-9 Secure Processing Unit Developed</div> |
| <div class="timeline-desc">Custom secure processing architecture with side-channel resistance, dedicated entropy sources, and hardware-enforced memory isolation. Distinct from HSPA-8. <span class="auth-id">[SG-003]</span> <span class="auth-id">[SG-006]</span></div> |
| </div> |
| <div class="timeline-item"> |
| <div class="timeline-date">Ongoing</div> |
| <div class="timeline-title">GPRS-Secure++ Genomic Pipeline Deployed</div> |
| <div class="timeline-desc">Cross-domain data handling with federated computation, differential privacy, and patient-controlled consent. Supports HIPAA, GINA, ADA, GDPR compliance. <span class="auth-id">[SG-001]</span> <span class="auth-id">[SG-002]</span> <span class="auth-id">[LF-002]</span></div> |
| </div> |
| <div class="timeline-item"> |
| <div class="timeline-date">Ongoing</div> |
| <div class="timeline-title">Baltimore Secure Backbone System (BSBS) Established</div> |
| <div class="timeline-desc">Municipal-grade zero-trust infrastructure with Fort McHenry HSM, SHA3-256 Merkle trees, certificate transparency, and fail-closed protocols. Mapped to NIST SP 800-207 / 800-53 Rev. 5. <span class="auth-id">[SG-003]</span> <span class="auth-id">[SG-005]</span> <span class="auth-id">[LF-003]</span></div> |
| </div> |
| <div class="timeline-item active"> |
| <div class="timeline-date">June 22, 2026</div> |
| <div class="timeline-title">Official Order Request — USEC Senior Notes</div> |
| <div class="timeline-desc">Execution-ready order for institutional acquisition of USEC Inc. senior notes under Master Authority Matrix governance. Multi-signature authorization, BSBS custody protocols, and post-quantum audit trail implemented. <span class="auth-id">[EX-SE-003]</span> <span class="auth-id">[SG-005]</span> <span class="auth-id">[SG-006]</span> <span class="auth-id">[LF-003]</span></div> |
| </div> |
| <div class="timeline-item"> |
| <div class="timeline-date">Future</div> |
| <div class="timeline-title">PLA-Based Degree Completion</div> |
| <div class="timeline-desc">Prior Learning Assessment pathway at UMGC and BCCC for regulatory compliance training and academic credentialing in constitutional law, bioinformatics, and municipal policy. <span class="auth-id">[DA-004]</span> <span class="auth-id">[SR-003]</span></div> |
| </div> |
| </div> |
| </section> |
|
|
| |
| <footer class="footer"> |
| <div class="footer-links"> |
| <a href="#matrix">Authority Matrix</a> |
| <a href="#projects">Projects</a> |
| <a href="#exhibits">Exhibits</a> |
| <a href="#securities">Securities</a> |
| <a href="#timeline">Timeline</a> |
| </div> |
| <p>Caustin IP & Public Trust Platform | Baltimore, Maryland 21223</p> |
| <p style="margin-top:8px; font-size:0.75rem; opacity:0.4;"> |
| Constitutional Law • Bioinformatics • AI Architecture • Municipal Policy<br> |
| BSBS | GPRS-Secure++ | HSPA-9 | Master Authority Matrix v1.0 |
| </p> |
| </footer> |
|
|
| <script> |
| |
| const observer = new IntersectionObserver((entries) => { |
| entries.forEach(entry => { |
| if (entry.isIntersecting) { |
| entry.target.classList.add('visible'); |
| } |
| }); |
| }, { threshold: 0.1 }); |
| |
| document.querySelectorAll('.fade-in').forEach(el => observer.observe(el)); |
| |
| |
| const sections = document.querySelectorAll('section[id]'); |
| const navLinks = document.querySelectorAll('.nav-links a'); |
| |
| window.addEventListener('scroll', () => { |
| let current = ''; |
| sections.forEach(section => { |
| const sectionTop = section.offsetTop - 80; |
| if (scrollY >= sectionTop) { |
| current = section.getAttribute('id'); |
| } |
| }); |
| navLinks.forEach(link => { |
| link.classList.remove('active'); |
| if (link.getAttribute('href') === '#' + current) { |
| link.classList.add('active'); |
| } |
| }); |
| }); |
| |
| |
| document.querySelectorAll('a[href^="#"]').forEach(anchor => { |
| anchor.addEventListener('click', function(e) { |
| e.preventDefault(); |
| const target = document.querySelector(this.getAttribute('href')); |
| if (target) { |
| target.scrollIntoView({ behavior: 'smooth', block: 'start' }); |
| } |
| }); |
| }); |
| </script> |
|
|
| </body> |
| </html> |
